Edwards Lifesciences Corporation
MX ˙ BMV ˙ US28176E1082
SecurityMX:EW / Edwards Lifesciences Corporation
InstitutionAdvisorNet Financial, Inc
Latest Disclosed Ownership1,953 shares
Latest Disclosed Value $ 156,396
AdvisorNet Financial, Inc reports 0.67% increase in ownership of EW / Edwards Lifesciences Corporation

On April 17, 2026 - AdvisorNet Financial, Inc filed a 13F-HR form disclosing ownership of 1,953 shares of Edwards Lifesciences Corporation (MX:EW) valued at $156,396 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 20, 2026 disclosing 1,940 shares of Edwards Lifesciences Corporation. This represents a change in shares of 0.67% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-17 2026-03-31 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 1,953 13 0.67 156 -5.45 0.0081
2026-01-20 2025-12-31 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 1,940 267 15.96 165 26.92 0.0088
2025-10-09 2025-09-30 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 1,673 12 0.72 130 0.78 0.0074
2025-07-14 2025-06-30 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 1,661 -2 -0.12 130 7.50 0.0084
2025-04-07 2025-03-31 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 1,663 172 11.54 121 9.09 0.0089
2025-01-13 2024-12-31 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 1,491 -341 -18.61 110 -8.33 0.0092
2024-10-15 2024-09-30 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 1,832 -192 -9.49 121 -35.48 0.0090
2024-07-16 2024-06-30 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 2,024 0 0.00 187 -3.63 0.0170
2024-04-12 2024-03-31 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 2,024 -94 -4.44 193 19.88 0.0186
2024-01-19 2023-12-31 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 2,118 273 14.80 161 26.77 0.0149
2023-10-12 2023-09-30 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 1,845 58 3.25 128 -24.40 0.0116
2023-07-14 2023-06-30 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 1,787 -46 -2.51 169 11.26 0.0144
2023-04-28 2023-03-31 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 1,833 188 11.43 152 23.77 0.0139
2023-01-13 2022-12-31 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 1,645 51 3.20 123 -7.58 0.0121
2022-10-04 2022-09-30 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 1,594 -180 -10.15 132 -21.89 0.0132
2022-07-07 2022-06-30 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 1,774 -125 -6.58 169 -24.55 0.0166
2022-04-14 2022-03-31 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 1,899 252 15.30 224 5.16 0.0141
2022-01-19 2021-12-31 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 1,647 -112 -6.37 213 7.04 0.0131
2021-10-15 2021-09-30 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 1,759 775 78.76 199 95.10 0.0138
2021-07-06 2021-06-30 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 984 0 0.00 102 24.39 0.0068
2021-04-14 2021-03-31 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 984 0 0.00 82 -8.89 0.0058
2021-02-04 2020-12-31 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 984 -58 -5.57 90 8.43 0.0073
2020-11-06 2020-09-30 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 1,042 -86 -7.62 83 6.41 0.0071
2020-08-26 2020-06-30 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 1,128 795 238.74 78 23.81 0.0063
2020-05-14 2020-03-31 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 333 0 0.00 63 -19.23 0.0058
2020-02-12 2019-12-31 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 333 0 0.00 78 6.85 0.0066
2019-10-23 2019-09-30 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 333 95 39.92 73 65.91 0.0067
2019-07-15 2019-06-30 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 238 0 0.00 44 -4.35 0.0049
2019-05-14 2019-03-31 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 238 0 0.00 46 27.78 0.0056
2019-02-08 2018-12-31 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 238 0 0.00 36 -12.20 0.0050
2018-11-14 2018-09-30 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 238 -12 -4.80 41 13.89 0.0052
2018-07-26 2018-06-30 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 250 31 14.16 36 16.13 0.0049
2018-05-08 2018-03-31 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 219 0 0.00 31 24.00 0.0043
2018-02-27 2017-12-31 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 219 219 25 0.0038
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.